Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Chiaretti

Showing results (91-100 of 172) with videos related to

Pageof 18
Sort By:
Neoplasia (New York, N.Y.)|August 4, 2009
Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutationsLudovica Ciuffreda, Donatella Del Bufalo, Marianna Desideri, et al.
Blood|February 2, 2024
Management of ALL in adults: 2024 ELN recommendations from a European expert panelNicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, et al.
Blood|January 31, 2024
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panelNicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, et al.
American Journal of Hematology|March 22, 2022
Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trialGiovanni Fernando Torelli, Sabina Chiaretti, Nadia Peragine, et al.
Leukemia & Lymphoma|September 28, 2019
Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with <i>Ebf1-Pdgfrb</i> fusion transcriptFrancesca Fazio, Walter Barberi, Gianni Cazzaniga, et al.
American Journal of Hematology|September 14, 2013
Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosisIlaria Del Giudice, Sabina Chiaretti, Simona Santangelo, et al.
Leukemia & Lymphoma|May 4, 2019
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemiaIrene Della Starza, Lucia Anna De Novi, Alessandra Santoro, et al.
Genes, Chromosomes & Cancer|February 4, 2015
Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212Simona Tavolaro, Teresa Colombo, Sabina Chiaretti, et al.
Leukemia & Lymphoma|December 19, 2022
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findingsSabina Chiaretti, Akram Taherinasab, Irene Della Starza, et al.
Haematologica|May 7, 2016
Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemiaRoberta La Starza, Gianluca Barba, Sofie Demeyer, et al.
Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:
Pageof 18
Neoplasia (New York, N.Y.)|August 4, 2009
Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutationsLudovica Ciuffreda, Donatella Del Bufalo, Marianna Desideri, et al.
Blood|February 2, 2024
Management of ALL in adults: 2024 ELN recommendations from a European expert panelNicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, et al.
Blood|January 31, 2024
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panelNicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, et al.
American Journal of Hematology|March 22, 2022
Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trialGiovanni Fernando Torelli, Sabina Chiaretti, Nadia Peragine, et al.
Leukemia & Lymphoma|September 28, 2019
Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with <i>Ebf1-Pdgfrb</i> fusion transcriptFrancesca Fazio, Walter Barberi, Gianni Cazzaniga, et al.
American Journal of Hematology|September 14, 2013
Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosisIlaria Del Giudice, Sabina Chiaretti, Simona Santangelo, et al.
Leukemia & Lymphoma|May 4, 2019
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemiaIrene Della Starza, Lucia Anna De Novi, Alessandra Santoro, et al.
Genes, Chromosomes & Cancer|February 4, 2015
Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212Simona Tavolaro, Teresa Colombo, Sabina Chiaretti, et al.
Leukemia & Lymphoma|December 19, 2022
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findingsSabina Chiaretti, Akram Taherinasab, Irene Della Starza, et al.
Haematologica|May 7, 2016
Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemiaRoberta La Starza, Gianluca Barba, Sofie Demeyer, et al.
Pageof 18